However, individual results vary based on genetics, metabolism, and dosing adherence
These probabilities matter when you are deciding which medication to try first, because time spent on a less effective option is time without the metabolic benefits a more effective option might provide
Ozempic is the injection version of Semaglutide, it is approved use for lower blood sugar levels for type two diabetic patients, along with diet and exercise
On the difference in weight-loss effects, Cho said, For non-diabetic patients, Wegovy results in about 15 percent weight loss and Mounjaro about 20 percent
It's a simple way to support your weight loss progressespecially when combined with healthy eating and regular movement
Cody Belkoff, DO a board-certified osteopathic physician with over 15 years of clinical experience